DNA regulator offers new hope for Hodgkin lymphoma treatment
Researchers at The Australian National University (ANU) have discovered how a DNA-binding protein sustains Hodgkin lymphoma.
Jul 21, 2021
0
91
Researchers at The Australian National University (ANU) have discovered how a DNA-binding protein sustains Hodgkin lymphoma.
Jul 21, 2021
0
91
New research uncovers substantial differences in rates of childhood cancers when considering single year of age rather than grouping several years together. The study published by Wiley early online in Cancer, a peer-reviewed ...
Jun 21, 2021
0
1
Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The main two subtypes are Hodgkin lymphoma and non-Hodgkin lymphoma. Because of breakthrough research, this once fatal diagnosis ...
Mar 31, 2021
0
2
A first-of-its-kind Australian study has revealed rates of brain lymphoma have quadrupled since the 1980s with only 33% of people surviving five years after receiving a diagnosis.
Feb 2, 2021
0
1
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer ...
Dec 5, 2020
0
187
A seven-year-old yellow English Lab, Jake is a "big goofy guy with a giant smile," said his owner, Danielle Sweder of Marlborough, Mass. "He's always happy and loves to eat, play, and spread joy to others with his infectious ...
Oct 27, 2020
0
1
Targeting a "cell survival" protein could be a valuable new approach to treating certain blood cancers associated with Epstein-Barr virus (EBV), according to research resulting from a collaboration between scientists at the ...
Oct 7, 2020
0
23
The National Comprehensive Cancer Network (NCCN) today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Hodgkin Lymphoma. Hodgkin lymphoma is one of the most curable ...
Sep 28, 2020
0
3
The National Institute for Health and Care Excellence (NICE) has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.
Aug 21, 2020
0
1
Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) and The Ohio State University Wexner Medical Center are conducting ...
Jul 29, 2020
0
3